Daily Aspirin Use and Cancer Mortality in a Large US Cohort | Zendy

Eric J. Jacobs | Zendy; Christina C. Newton | Zendy; Susan M. Gapstur | Zendy; Michael J. Thun | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Daily Aspirin Use and Cancer Mortality in a Large US Cohort

Author(s) -

Eric J. Jacobs,

Christina C. Newton,

Susan M. Gapstur,

Michael J. Thun

Publication year - 2012

Publication title -

jnci journal of the national cancer institute

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.797

H-Index - 356

eISSN - 1460-2105

pISSN - 0027-8874

DOI - 10.1093/jnci/djs318

Subject(s) - aspirin , medicine , relative risk , confidence interval , cancer , cohort , cohort study , cancer prevention , proportional hazards model , demography , surgery , sociology

A recent pooled analysis of randomized trials of daily aspirin for prevention of vascular events found a substantial reduction (relative risk [RR] = 0.63, 95% confidence interval [CI] = 0.49 to 0.82) in overall cancer mortality during follow-up occurring after 5 years on aspirin. However, the magnitude of the effect of daily aspirin use, particularly long-term use, on cancer mortality is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research